Prostate Cancer Clinical Trials in Evanston, Illinois
4 studies are recruiting for prostate cancer in Evanston, Illinois right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
Hormone therapy, or androgen deprivation therapy (ADT) is a standard way to treat prostate cancer. It works by reducing the amount of the main male sex hormone, testosterone in the body. Androgen receptor pathway inhibitors (ARPIs) are another type of hormone therapy. They either slow down how much…
- Stage
- Phase 2
- Ages
- 18 and older
- Site
- NorthShore University HealthSystem, Evanston, Illinois
- Locations
- 54 in total
- Run by
- Astellas Pharma Global Development, Inc.
-
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
Researchers conducting this study hope to learn about the safety and effectiveness of combining two study drugs, relacorilant and enzalutamide, plus androgen deprivation therapy (ADT), also known as hormone therapy. This study is for individuals who have been diagnosed with advanced, high-risk pros…
- Stage
- Phase 2
- Ages
- 18 and older
- Site
- Endeavor Health, Evanston, Illinois
- Locations
- 4 in total
- Run by
- University of Chicago
-
Precision-Based Genomics in Prostate Cancer
Background: Prostate cancer is the most common cancer and the second leading cause of death in males in the United States. Researchers want to find additional gene mutations that may increase a man s risk for prostate cancer and may affect how aggressive the disease is. Objective: To look at gene m…
- Stage
- Not phased
- Ages
- 18 to 120
- Site
- NorthShore University HealthSystem, Evanston, Illinois
- Locations
- 11 in total
- Run by
- National Cancer Institute (NCI)
-
Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy
Condition: Prostate cancer Intervention: Biopsy and inherited risk assessment
- Stage
- Not phased
- Ages
- 40 to 69
- Site
- NorthShore University HealthSystem, Evanston, Illinois
- Run by
- Endeavor Health
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.